Shukra Pharmaceuticals Limited - ROE

The ROE as of September 2026 (TTM) for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is 43.67%

According to Shukra Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is 43.67%. This represents a change of 271.06% compared to the average of 11.77% of the last 4 quarters.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Historical ROE (quarterly & annually)

How has SHUKRAPHAR.BO ROE performed in the past?

The mean historical ROE of Shukra Pharmaceuticals Limited over the last ten years is 10.54%. The current 43.67% ROE has changed 314.48% with respect to the historical average. Over the past ten years (40 quarters), SHUKRAPHAR.BO's ROE was at its highest in in the December 2025 quarter at 30.95%. The ROE was at its lowest in in the March 2020 quarter at -2.62%.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) ROE by Quarter and Year

Discovering the peaks and valleys of Shukra Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) Average ROE

How has SHUKRAPHAR.BO ROE performed in the past?

The current ROE of Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) ROE vs. Peers

How is SHUKRAPHAR.BO’s ROE compared to its peers?

Shukra Pharmaceuticals Limited’s ROE is less than Suraksha Diagnostic Ltd. (15.65%), less than Suraksha Diagnostic Ltd. (15.65%), less than TTK Healthcare Limited (6.72%), less than Sigma Advanced Systems Limited (101.99%), less than Bliss GVS Pharma Limited (11.53%), less than Bliss GVS Pharma Limited (11.53%), less than Tarsons Products Limited (1.76%), less than Tarsons Products Limited (1.76%), less than Syncom Formulations (India) Limited (21.56%), less than Syncom Formulations (India) Limited (21.56%),

Build a custom stock screener for Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shukra Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shukra Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.